| P2093 | author name string | Katsikogiannis N | |
| | Kougioumtzi I | |
| | Machairiotis N | |
| | Zarogoulidis K | |
| | Zarogoulidis P | |
| | Charitos C | |
| | Argiriou M | |
| | Arikas S | |
| | Beleveslis T | |
| | Koletas A | |
| | Mpakas A | |
| | Sakellaridis T | |
| | Tsakiridis K | |
| | Tsiouda T | |
| P2860 | cites work | Left atrial appendage: structure, function, and role in thromboembolism | Q24670160 |
| | Left atrial appendages from adult hearts contain a reservoir of diverse cardiac progenitor cells | Q27334201 |
| | Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation | Q28201331 |
| | Validation of Clinical Classification Schemes for Predicting Stroke | Q29028208 |
| | Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage | Q30417404 |
| | Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience | Q34127331 |
| | Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation | Q34266837 |
| | The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial | Q34518553 |
| | Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. | Q34607412 |
| | Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752573 |
| | Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillation | Q36087921 |
| | Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation | Q37141681 |
| | Is the left atrial appendage more than a simple appendage? | Q37441030 |
| | Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? | Q37639806 |
| | Left atrial appendage exclusion: state-of-the-art. | Q37678317 |
| | Left atrial appendage closure | Q37764740 |
| | Surgical strategies and devices for surgical exclusion of the left atrial appendage: a word of caution | Q38075000 |
| | Left atrial appendage occlusion and ligation devices: what is available, how to implement them, and how to manage and avoid complications. | Q39570419 |
| | Left atrial appendage occlusion by invagination and double suture technique | Q39875085 |
| | Guidelines on the management of valvular heart disease (version 2012). | Q40276570 |
| | The WATCHMAN left atrial appendage closure device for atrial fibrillation | Q42241079 |
| | Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42874726 |
| | Left atrial appendage occlusion eliminates the need for warfarin | Q43245380 |
| | Surgical closure of the left atrial appendage in patients with atrial fibrillation. Indications, techniques and results | Q43858231 |
| | Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience | Q43897262 |
| | Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in nonvalvular atrial fibrillation. | Q45907164 |
| | Amplatzer left atrial appendage occlusion: single center 10-year experience | Q48090068 |
| | Use of tissue welding technology to obliterate left atrial appendage--novel use of Ligasure. | Q50945772 |
| | ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease | Q54165758 |
| | Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). | Q55056619 |
| | ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ | Q56626176 |
| | HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablatio | Q58815045 |
| | The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience | Q85935423 |
| | The new ESC/EACTS guidelines on the management of valvular heart disease | Q87437639 |
| | ESC/EACTS Guidelines on the management of valvular heart disease | Q95423931 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S70-7 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Journal of thoracic disease | Q26841814 |
| P1476 | title | Left atrial appendage exclusion-Where do we stand? | |
| P478 | volume | 6 Suppl 1 | |